wavelength-pharmaceuticals-m-2020-09-21

nextFEATURED COMPANIESprevious

OUR PARTNER COMPANIES

nextINTERVIEWS #SpeakPharmaprevious SEE
ALL

“Polpharma API’s ability to control particle size distribution resolves multiple formulation challenges for our clients”

This week, SpeakPharma interviews three experts from Poland’s leading pharmaceutical company, ...

PharmaCompass.com

“India’s time to become the pharmacy of the world has arrived”

This week, Parul Oza is back on SpeakPharma to take us through the changes the global pharmaceutica...

PharmaCompass.com

“In these unprecedented times, organizations need to get creative in their client outreach”

At a time when all conferences are getting cancelled or indefinitely postponed, SpeakPharma intervie...

PharmaCompass.com

“Wavelength’s strategy to continuously invest in its supply chain has proven itself during the Covid-19 pandemic”

This week, SpeakPharma interviews Ilan Avni, Vice President, Business Development at Wavelength Ph...

PharmaCompass.com

“Competitors in the outsourcing world have come together to fight the pandemic”

This week, SpeakPharma interviews Frédéric Gaussens, Vice President, Business Developm...

PharmaCompass.com

“With Qualit-e Cloud, producers save precious time spent in emailing documents to their customers”

This week, SpeakPharma interviews Nadine Blaettler, Founder and CEO of Switzerland-based Qualit-e Cl...

PharmaCompass.com

nextNEWS & ALERTSprevious

TOP 10 NEWS OF THE DAY SEE
ALL

NEWS LIBRARY

nextMARKET PLACEprevious

LATEST ENQUIRIES

nextBLOG & ANALYSISprevious

BLOG #phispers #pharmaflow
Post an enquiry PharmaCompass.com
SEE
ALL

Gilead acquires Immunomedics for US$ 21 billion; FDA issues guidance on resuming normal manufacturing

This week, Phispers brings you news of two deals in the antibody drug conjugates (ADCs) space. Whi...

Radio Compass

PharmaCompass.com

USFDA’s list of drugs that need generic alternatives

In its continuous endeavor to bolster the competitiveness of the generics market, the US Food...

Radio Compass

PharmaCompass.com

CEOs pledge to prioritize science for safe Covid vaccine; AstraZeneca-Oxford put phase 3 trials on hold

This week, Phispers brings you crucial news on vaccine development to control the ongoing Covid-19 p...

Radio Compass

PharmaCompass.com

previousPIPELINE PROSPECTOR SEE
ALL

Pipeline Prospector Deals Insights: Mid-2020 Recap

The year 2020 will be remembered as the year when life as we knew it came to a grinding halt and c...

05 August 2020

PharmaCompass.com

Pipeline Prospector March 2020: Deal Updates & Coronavirus Developments

In February, PharmaCompass and SCORR Marketing had announced the launch of the Pipeline Prosp...

09 April 2020

PharmaCompass.com

Pipeline Prospector April 2020: Pharma, biotech deals gain momentum; focus shifts from Covid-19

As the world continued to battle the Covid-19 pandemic, global drug deals and development activiti...

21 May 2020

PharmaCompass.com

Pipeline Prospector Feb 2020: Coronavirus Developments & Deal Updates

In February, PharmaCompass and SCORR Marketing had announced the launch of the Pipeline Prosp...

19 March 2020

PharmaCompass.com